US233A - Improvement in plows - Google Patents
Improvement in plows Download PDFInfo
- Publication number
- US233A US233A US233DA US233A US 233 A US233 A US 233A US 233D A US233D A US 233DA US 233 A US233 A US 233A
- Authority
- US
- United States
- Prior art keywords
- landside
- improvement
- plows
- edge
- share
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000001699 lower leg Anatomy 0.000 description 4
- 210000003467 Cheek Anatomy 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 230000000717 retained Effects 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B61—RAILWAYS
- B61F—RAIL VEHICLE SUSPENSIONS, e.g. UNDERFRAMES, BOGIES OR ARRANGEMENTS OF WHEEL AXLES; RAIL VEHICLES FOR USE ON TRACKS OF DIFFERENT WIDTH; PREVENTING DERAILING OF RAIL VEHICLES; WHEEL GUARDS, OBSTRUCTION REMOVERS OR THE LIKE FOR RAIL VEHICLES
- B61F17/00—Lubrication specially adapted for axle-boxes of rail vehicles
- B61F17/02—Lubrication specially adapted for axle-boxes of rail vehicles with oil
- B61F17/04—Lubrication by stationary devices
- B61F17/06—Lubrication by stationary devices by means of a wick or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S149/00—Explosive and thermic compositions or charges
- Y10S149/117—Smoke or weather composition contains resin
Definitions
- Fig. 3 is a view of the landside of my plow, within a recess or depression in which I place a reversing cutter, g g g, the general form of which is that of a triangle, either end of which may be turned forward, so as to constitute the cutting-edge formed by the junction of the mold-board and landside of the plow.
- This reversing cutter may be fastened in its place by making it hollow, so as to receive the part h of the landside, allowing space enough between the piece h and the cutter .to insert a wedge or wedges, i.
- the edges of h are made dovetailing or beveled, to clip the inner edges of g and holditfirmlyagainstthelandsidewhen wedged.
- One of theedges of g may reach to the bottom of the landside; or it may stand a little above it, having the strip of iron 9 below it, which strip in this case forms a side of the recess.
- the reversing cutter received into a recess or the landside and capable of having either of its edges presented forward, so as to form the cutting-edge of the plow, and secured in its place on the landside by a wedge or wedges, or in any other manner which may be preferred.
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Piles And Underground Anchors (AREA)
Description
May 29, 1915.
DRAWING A careful search has been made this day for the original drawing or a photolithographic copy of the same,
for the purpose of reproducing the said drawing to form a part of this book, but at this time nothing can be found from which a reproduction can be made.
Finis D Morris,
Chief of Division E.
NrTED PATENT Fries.
BANOROFT WOODCOCK, OF MOUNT PLEASANT, PENNSYLVANIA.
IMPROVEMENT IN PLOWS.
To all whom it may concern:
Be it known that I, BANOROF'J. WooDcooK, of Mount Pleasant, in the county of Westmoreland. and State of Pennsylvania, have invented certain Improvements in Flows; and I do hereby declare that the following is a full and exact description thereof.
The share which I use is the same in its general form as that described by me in the specification annexed to Letters Patent granted to me on the 23d day of November, 1836; but it dilfers therefrom in its transverse section a b, Figure 2, through the part represented by the dotted line a b, Fig. 1. The face on each side has its surface flat from each cutting-edge to a shoulder, represented by the line 0 d on one side and on the opposite side by the dotted line of. By this means I am enabled to make the share so thin throughout its width that as it wears up toward the mold-board it is still sufficiently soon its edge to pass freelythrough the ground. It has two holes, xx, through it, by one or the other of which it is bolted to the mold-board.
Fig. 3 is a view of the landside of my plow, within a recess or depression in which I place a reversing cutter, g g g, the general form of which is that of a triangle, either end of which may be turned forward, so as to constitute the cutting-edge formed by the junction of the mold-board and landside of the plow. This reversing cutter may be fastened in its place by making it hollow, so as to receive the part h of the landside, allowing space enough between the piece h and the cutter .to insert a wedge or wedges, i. The edges of h are made dovetailing or beveled, to clip the inner edges of g and holditfirmlyagainstthelandsidewhen wedged. One of theedges of g may reach to the bottom of the landside; or it may stand a little above it, having the strip of iron 9 below it, which strip in this case forms a side of the recess.
.1 have also made an improvement in the manner of making the renewable point. For the mode in which I formerly made it I refer to the description thereof in the Letters Patent above named. I now prepare a V-formed piece of iron or steel, which fits onto the shank 70, Fig. 3, embracing it on both sides, as shown at Z l,.and fastened to it by a rivet passing through the whole. The renewable point is thus rendered more permanent than upon the the former plan, and the shank is perfectly protected from grinding out in wear.
In order to secure the landside to the moldboard, 1 cast the fitting parts with dovetail junctures in such a way as that, when secured together by wedges passed between cheeks adapted to that purpose, the parts interlock,
'and are retained firmly in their places.
What I claim in reference to the share is- 1. Making it with plain surfaces instead of curved ones, in the manner described, continuing such surfaces to the shoulder on each side, so as to leave the metal throughout so thin that when it wears off by use the share will still present a thin edge to the ground.
2. The reversing cutter, received into a recess or the landside and capable of having either of its edges presented forward, so as to form the cutting-edge of the plow, and secured in its place on the landside by a wedge or wedges, or in any other manner which may be preferred.
3. The mode of forming the renewable point, as herein. specifically set forth.
BANC-ROFT VOODCOUK. Witnesses:
THos. I. JoNEs, M. E. J ONES.
Publications (1)
Publication Number | Publication Date |
---|---|
US233A true US233A (en) | 1837-06-14 |
Family
ID=2060512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US233D Expired - Lifetime US233A (en) | Improvement in plows |
Country Status (1)
Country | Link |
---|---|
US (1) | US233A (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120267016A1 (en) * | 2011-04-19 | 2012-10-25 | Lombardi John L | Nontoxic Obscurant Compositions and Method of Using Same |
WO2014153063A1 (en) | 2013-03-14 | 2014-09-25 | Amgen Inc. | AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES |
WO2016166360A1 (en) | 2015-04-17 | 2016-10-20 | Bayer Pharma Aktiengesellschaft | Bispecific antibody constructs for cdh3 and cd3 |
EP3456743A1 (en) | 2013-05-30 | 2019-03-20 | Kiniksa Pharmaceuticals, Ltd. | Oncostatin m receptor antigen binding proteins |
WO2019070901A1 (en) | 2017-10-04 | 2019-04-11 | Amgen Inc. | Transthyretin immunoglobulin fusions |
WO2020025596A1 (en) | 2018-07-31 | 2020-02-06 | Amgen Research (Munich) Gmbh | Dosing regimen for bcma-cd3 bispecific antibodies |
WO2020025792A1 (en) | 2018-08-03 | 2020-02-06 | Amgen Research (Munich) Gmbh | Antibody constructs for cldn18.2 and cd3 |
WO2020025532A1 (en) | 2018-07-30 | 2020-02-06 | Amgen Research (Munich) Gmbh | Prolonged administration of a bispecific antibody construct binding to cd33 and cd3 |
WO2021007150A1 (en) | 2019-07-08 | 2021-01-14 | Amgen Inc. | Multispecific transthyretin immunoglobulin fusions |
WO2021030602A1 (en) | 2019-08-13 | 2021-02-18 | Amgen Inc. | Interleukin-2 muteins for the expansion of t-regulatory cells |
EP3819007A1 (en) | 2019-11-11 | 2021-05-12 | Amgen Research (Munich) GmbH | Dosing regimen for anti-bcma agents |
WO2021108647A1 (en) | 2019-11-27 | 2021-06-03 | Crispr Therapeutics Ag | Methods of synthesizing rna molecules |
WO2021127262A1 (en) | 2019-12-17 | 2021-06-24 | Amgen Inc. | Dual interleukin-2 /tnf receptor agonist for use in therapy |
WO2021150824A1 (en) | 2020-01-22 | 2021-07-29 | Amgen Research (Munich) Gmbh | Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof |
EP3865514A1 (en) | 2015-07-31 | 2021-08-18 | Amgen Research (Munich) GmbH | Bispecific antibody constructs binding dll3 and cd3 |
EP3912999A1 (en) | 2015-07-31 | 2021-11-24 | Amgen Research (Munich) GmbH | Bispecific antibody constructs binding egfrviii and cd3 |
WO2021243320A2 (en) | 2020-05-29 | 2021-12-02 | Amgen Inc. | Adverse effects-mitigating administration of a bispecific antibody construct binding to cd33 and cd3 |
WO2022103781A1 (en) | 2020-11-10 | 2022-05-19 | Amgen Inc. | Methods for administering a bcma x cd3 binding molecule |
EP4101928A1 (en) | 2021-06-11 | 2022-12-14 | Bayer AG | Type v rna programmable endonuclease systems |
WO2022258753A1 (en) | 2021-06-11 | 2022-12-15 | Bayer Aktiengesellschaft | Type v rna programmable endonuclease systems |
EP4144841A1 (en) | 2021-09-07 | 2023-03-08 | Bayer AG | Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof |
WO2023078968A1 (en) | 2021-11-03 | 2023-05-11 | Affimed Gmbh | Bispecific cd16a binders |
WO2023079493A1 (en) | 2021-11-03 | 2023-05-11 | Affimed Gmbh | Bispecific cd16a binders |
EP4219562A2 (en) | 2015-07-31 | 2023-08-02 | Amgen Research (Munich) GmbH | Antibody constructs for flt3 and cd3 |
WO2023237587A1 (en) | 2022-06-10 | 2023-12-14 | Bayer Aktiengesellschaft | Novel small type v rna programmable endonuclease systems |
EP4327885A2 (en) | 2015-07-31 | 2024-02-28 | Amgen Research (Munich) GmbH | Antibody constructs for msln and cd3 |
-
0
- US US233D patent/US233A/en not_active Expired - Lifetime
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120267016A1 (en) * | 2011-04-19 | 2012-10-25 | Lombardi John L | Nontoxic Obscurant Compositions and Method of Using Same |
WO2014153063A1 (en) | 2013-03-14 | 2014-09-25 | Amgen Inc. | AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES |
EP4349864A2 (en) | 2013-05-30 | 2024-04-10 | Kiniksa Pharmaceuticals, Ltd. | Oncostatin m receptor antigen binding proteins |
EP3456743A1 (en) | 2013-05-30 | 2019-03-20 | Kiniksa Pharmaceuticals, Ltd. | Oncostatin m receptor antigen binding proteins |
EP3971212A1 (en) | 2013-05-30 | 2022-03-23 | Kiniksa Pharmaceuticals, Ltd. | Oncostatin m receptor antigen binding proteins |
EP4276116A2 (en) | 2015-04-17 | 2023-11-15 | Amgen Research (Munich) GmbH | Bispecific antibody constructs for cdh3 and cd3 |
WO2016166360A1 (en) | 2015-04-17 | 2016-10-20 | Bayer Pharma Aktiengesellschaft | Bispecific antibody constructs for cdh3 and cd3 |
EP4219562A2 (en) | 2015-07-31 | 2023-08-02 | Amgen Research (Munich) GmbH | Antibody constructs for flt3 and cd3 |
EP4327885A2 (en) | 2015-07-31 | 2024-02-28 | Amgen Research (Munich) GmbH | Antibody constructs for msln and cd3 |
EP3912999A1 (en) | 2015-07-31 | 2021-11-24 | Amgen Research (Munich) GmbH | Bispecific antibody constructs binding egfrviii and cd3 |
EP3865514A1 (en) | 2015-07-31 | 2021-08-18 | Amgen Research (Munich) GmbH | Bispecific antibody constructs binding dll3 and cd3 |
WO2019070901A1 (en) | 2017-10-04 | 2019-04-11 | Amgen Inc. | Transthyretin immunoglobulin fusions |
WO2020025532A1 (en) | 2018-07-30 | 2020-02-06 | Amgen Research (Munich) Gmbh | Prolonged administration of a bispecific antibody construct binding to cd33 and cd3 |
WO2020025596A1 (en) | 2018-07-31 | 2020-02-06 | Amgen Research (Munich) Gmbh | Dosing regimen for bcma-cd3 bispecific antibodies |
WO2020025792A1 (en) | 2018-08-03 | 2020-02-06 | Amgen Research (Munich) Gmbh | Antibody constructs for cldn18.2 and cd3 |
WO2021007150A1 (en) | 2019-07-08 | 2021-01-14 | Amgen Inc. | Multispecific transthyretin immunoglobulin fusions |
EP4385573A2 (en) | 2019-08-13 | 2024-06-19 | Amgen Inc. | Interleukin-2 muteins for the expansion of t-regulatory cells |
WO2021030602A1 (en) | 2019-08-13 | 2021-02-18 | Amgen Inc. | Interleukin-2 muteins for the expansion of t-regulatory cells |
WO2021094000A1 (en) | 2019-11-11 | 2021-05-20 | Amgen Research (Munich) Gmbh | Dosing regimen for anti-bcma agents |
EP3819007A1 (en) | 2019-11-11 | 2021-05-12 | Amgen Research (Munich) GmbH | Dosing regimen for anti-bcma agents |
WO2021108647A1 (en) | 2019-11-27 | 2021-06-03 | Crispr Therapeutics Ag | Methods of synthesizing rna molecules |
WO2021127262A1 (en) | 2019-12-17 | 2021-06-24 | Amgen Inc. | Dual interleukin-2 /tnf receptor agonist for use in therapy |
WO2021150824A1 (en) | 2020-01-22 | 2021-07-29 | Amgen Research (Munich) Gmbh | Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof |
WO2021243320A2 (en) | 2020-05-29 | 2021-12-02 | Amgen Inc. | Adverse effects-mitigating administration of a bispecific antibody construct binding to cd33 and cd3 |
WO2022103781A1 (en) | 2020-11-10 | 2022-05-19 | Amgen Inc. | Methods for administering a bcma x cd3 binding molecule |
WO2022258753A1 (en) | 2021-06-11 | 2022-12-15 | Bayer Aktiengesellschaft | Type v rna programmable endonuclease systems |
EP4101928A1 (en) | 2021-06-11 | 2022-12-14 | Bayer AG | Type v rna programmable endonuclease systems |
EP4144841A1 (en) | 2021-09-07 | 2023-03-08 | Bayer AG | Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof |
WO2023078968A1 (en) | 2021-11-03 | 2023-05-11 | Affimed Gmbh | Bispecific cd16a binders |
WO2023079493A1 (en) | 2021-11-03 | 2023-05-11 | Affimed Gmbh | Bispecific cd16a binders |
WO2023237587A1 (en) | 2022-06-10 | 2023-12-14 | Bayer Aktiengesellschaft | Novel small type v rna programmable endonuclease systems |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US233A (en) | Improvement in plows | |
US476A (en) | Bancroft woodcock | |
US85A (en) | Bancroft woodcock | |
US260A (en) | Improvement in plows | |
US501A (en) | Improvement in plows | |
US184A (en) | Improvement in spokeshaves | |
US273A (en) | Improvement in plows | |
US4127A (en) | Improvement in plows | |
US295A (en) | Improvement in the construction of self-sharpening plows | |
US1004238A (en) | Subsoil-plow. | |
US638A (en) | Improvement in self-sharpening plows | |
US259A (en) | Improvement in plows | |
US1208267A (en) | Plow. | |
US604A (en) | Improvement in plows | |
US2132A (en) | Improvement in the construction of plows | |
US1008A (en) | Improvement in double-mold-board plows | |
US1469808A (en) | Dipper tooth | |
US954A (en) | Mode of laying off and dressing the runners of millstones | |
US327A (en) | Improvement in plows | |
US1360A (en) | Improvement in plows | |
US922A (en) | Improvement in plows | |
US750385A (en) | Joseph naidul | |
US992034A (en) | Detachable shovel-tooth point. | |
USX6338I1 (en) | Edmund m | |
US837494A (en) | Plow. |